LOU Yue,QIAO Song,WANG Yanwen, et al. #br# Non-motor Symptoms in Early Parkinson's Disease with Three Different Motor Subtypes [J]. Chinese General Practice, 2021, 24(12): 1487-1493. DOI: 10.12114/j.issn.1007-9572.2021.00.020.
楼跃,乔松,王晏雯等. 不同运动亚型早期帕金森病的非运动症状研究[J]. 中国全科医学, 2021, 24(12): 1487-1493. DOI: 10.12114/j.issn.1007-9572.2021.00.020.
[1]SIMON D K,TANNER C M,BRUNDIN P.Parkinson disease epidemiology,pathology,genetics,and pathophysiology[J].Clin Geriatr Med,2020 ,36(1):1-12.DOI:10.1016/j.cger.2019.08.002.
[2]BARONE P,ANTONINI A,COLOSIMO C,et al.The PRIAMO study:a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease[J].Mov Disord,2009,24(11):1641-1649.DOI:10.1002/mds.22643.
[3]SOLLINGER A B,GOLDSTEIN F C,LAH J J,et al.Mild cognitive impairment in Parkinson's disease:subtypes and motor characteristics[J].Park Relat Disord,2010,16(3):1-7.DOI:10.1016/j.parkreldis.2009.11.002.
[4]AYGUN D,TURKEL Y,ONAR M K,et al.Clinical REM sleep behavior disorder and motor subtypes in Parkinson's disease:a questionnaire-based study[J].Clin Neurol Neurosurg,2014,119:54-58.DOI:10.1016/j.clineuro.2014.01.011.
[5]STEBBINS G T,GOETZ C G,BURN D J,et al.How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale:comparison with the unified Parkinson's disease rating scale[J].Mov Disord,2013,28(5):668-670.DOI:10.1002/mds.25383.
[6]刘军.中国帕金森病的诊断标准(2016版)[J].中华神经科杂志,2016,49(4):268-271.
[7]GOETZ C G,TILLEY B C,SHAFTMAN S R,et al.Movement Disorder Society Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS):scale presentation and clinimetric testing results [J].Mov Disord,2008,23(15):2129-2170.DOI:10.1002/mds.22340.
[8]CHAUDHURI K R,MARTINEZ-MARTIN P,BROWN R G,et al.The metric properties of a novel non-motor symptoms scale for Parkinson's disease:results from an international pilot study[J].Mov Disord,2007,22(13):1901-1911.DOI:10.1002/mds.21596.
[9]OPARA J A,BROLA W,LEONARDI M,et al.Quality of life in Parkinson's disease[J].J Med Life,2012,5(4):375-381.
[10]DATTA A K,DAS D,BHATTACHARYYA K B,et al.Frontal assessment battery in Parkinson's disease:a study on 170 patients[J].Neurol India,2019,67(2):433-438.DOI:10.4103/0028-3886.258052.
[11]LOPEZ F V,SPLIT M,FILOTEO J V,et al.Does the geriatric depression scale measure depression in Parkinson's disease?[J].Int J Geriatr Psychiatry,2018,33(12):1662-1670.DOI:10.1002/gps.4970.
[12]STARKSTEIN S E,MAYBERG H S,PREZIOSI T J,et al.Reliability,validity,and clinical correlates of apathy in Parkinson's disease[J].J Neuropsychiatry Clin Neurosci,1992,4(2):134-139.DOI:10.1176/jnp.4.2.134.
[13]LOUTER M,AARDEN W C,LION J,et al.Recognition and diagnosis of sleep disorders in Parkinson's disease[J].J Neurol,2012,259(10):2031-2040.DOI:10.1007/s00415-012-6505-7.
[14]VISSER M,MARINUS J,STIGGELBOUT A M,et al.Assessment of autonomic dysfunction in Parkinson's disease:the SCOPA-AUT[J].Mov Disord,2004,19(11):1306-1312.DOI:10.1002/mds.20153.
[15]KANG G A,BRONSTEIN J M,MASTERMAN D L,et al.Clinical characteristics in early Parkinson's disease in a central california population-based study[J].Mov Disord,2005,20(9):1-7.DOI:10.1002/mds.20513.
[16]CHOI S M,KIM B C,CHO B H,et al.Comparison of two motor subtype classifications in de novo Parkinson's disease[J].Park Relat Disord,2018,54:74-78.DOI:10.1016/j.parkreldis.2018.04.021.
[17]MüLLER B,ASSMUS J,HERLOFSON K,et al.Importance of motor vs.non-motor symptoms for health-related quality of life in early Parkinson's disease[J].Park Relat Disord,2013,19(11):1027-1032.DOI:10.1016/J.PARKRELDIS.2013.07.010.
[18]ZHONG L L,SONG Y Q,CAO H,et al.The non-motor symptoms of Parkinson's disease of different motor types in early stage[J].Eur Rev Med Pharmacol Sci,2017,21(24):5745-5750.DOI:10.26355/eurrev_201712_14021.
[19]BA F,OBAID M,WIELER M,et al.Parkinson disease:the relationship between non-motor symptoms and motor phenotype[J].Can J Neurol Sci,2015,43(2):261-267.DOI:10.1017/cjn.2015.328.
[20]BAIANO C,BARONE P,TROJANO L,et al.Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease:a meta-analysis[J].Mov Disord,2020,35(1):45-54.DOI:10.1002/mds.27902.
[21]HU P P,LI Y H,MA H J,et al.Dissociation between source and item memory in Parkinson's disease[J].Chin Med J(Engl),2014,127(18):3224-3228.
[22]LEWIS P A,MIALL R C.Distinct systems for automatic and cognitively controlled time measurement:evidence from neuroimaging[J].Curr Opin Neurobiol,2003,13(2):250-255.DOI:10.1016/s0959-4388(03)00036-9.
[23]MEISER T.Analyzing stochastic dependence of cognitive processes in multidimensional source recognition[J].Exp Psychol,2014,61(5):402-415.DOI:10.1027/1618-3169/a000261.
[24]LENFELDT N,HOLMLUND H,LARSSON A,et al.Frontal white matter injuries predestine gait difficulties in Parkinson's disease[J].Acta Neurol Scand,2016,134(3):210-218.DOI:10.1111/ane.12532.
[25]AARSLAND D,TAYLOR J W.Psychiatric issues in cognitive impairment[J].Mov Disord,2014,29(5):651-662.DOI:10.1002/mds.25873.
[26]VAN ROODEN S M,COLAS F,MARTíNEZ-MARTíN P,
et al.Clinical subtypes of Parkinson's disease[J].Mov Disord,2011,26(1):51-58.DOI:10.1002/mds.23346.
[27]SUZUKI K,OKUMA Y,UCHIYAMA T,et al.Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease:a multicentre cross-sectional study[J].J Neurol Neurosurg Psychiatry,2017,88(11):953-959.DOI:10.1136/jnnp-2017-316136.
[28]AARSLAND D,MARSH L,SCHRAG A.Neuropsychiatric symptoms in Parkinson's disease[J].Mov Disord,2009,24(15):2175-2186.DOI:10.1002/mds.22589.
[29]ZHOU Z,MüLLER MLTM,KANEL P,et al.Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline[J].Neurology,2020,94(4):e376-383.DOI:10.1212/WNL.0000000000008683.
[30]LEVY R,DUBOIS B.Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits[J].Cereb Cortex,2006,16(7):916-928.DOI:10.1093/cercor/bhj043.
[31]MEROLA A,ROMAGNOLO A,COMI C,et al.Prevalence and burden of dysautonomia in advanced Parkinson's disease[J].Mov Disord,2017,32(5):796-797.DOI:10.1002/mds.26970.
[32]POSTUMA R B,GAGNON J F,PELLETIER A,et al.Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies[J].Mov Disord,2013,28(5):597-604.DOI:10.1002/mds.25445.
[33]UMEHARA T,OKA H,NAKAHARA A,et al.High norepinephrinergic orthostatic hypotension in early Parkinson's disease[J].Park Relat Disord,2018,55:97-102.DOI:10.1016/j.parkreldis.2018.05.025.
[34]LIU X,WEI B,BI Q,et al.MPtp-induced impairment of cardiovascular function[J].Neurotox Res,2020,38(1):27-37.DOI:10.1007/s12640-020-00182-4.
[35]JAIN S G.Cardiovascular dysautonomia in parkinson disease:from pathophysiology to pathogenesis[J].Neurobiol Dis,2012,46(3):572-580.DOI:10.1016/j.nbd.2011.10.025.
[36]CHRISTOPHER L,KOSHIMORI Y,LANG A E,et al.Uncovering the role of the insula in non-motor symptoms of Parkinson's disease[J].Brain,2014,137(8):2143-2154.DOI:10.1093/brain/awu084.
[37]ZIEMSSEN T,REICHMANN H.Non-motor dysfunction in Parkinson's disease[J].Park Relat Disord,2007,13(6):323-332.DOI:10.1016/j.parkreldis.2006.12.014.
[38]DEL-MONTE J,BAYARD S,GRAZIANI P,et al.Cognitive,emotional,and auto-activation dimensions of apathy in Parkinson's disease[J].Front Behav Neurosci,2017,11:230.DOI:10.3389/fnbeh.2017.00230.
[39]CHUNG S J,BAE Y J,JUN S,et al.Dysautonomia is associated with structural and functional alterations in Parkinson disease[J].Neurology,2019,92(13):e1456-1467.DOI:10.1212/WNL.0000000000007181.
[40]MCDONALD C,NEWTON J L,BURN D J.Orthostatic hypotension and cognitive impairment in Parkinson's disease:Causation or association[J].Mov Disord,2016,31(7):937-946.DOI:10.1002/mds.26632.